11th Symposium

Neurocognitive impairment


Gabriele Arendt, M.D.

Department Neurology, University Hospital of Duesseldorf, Germany

Gabriele Arendt, MD, is associate Professor in Neurology, University Hospital of Duesseldorf, Germany. Since 1987, she chairs the Neuro-AIDS out-patient department of the hospital with about 1100 patients/year. The Duesseldorf HIV cohort comprises by now almost 5000 patients. She acquired her medical and scientific degrees in the University of Duesseldorf, then specialised on psychiatry and later on neurology and neurophysiology. Her scientific interest focuses on motor abnormalities in HIV-positive patients, disturbances of the dopaminergic pathways in these patients and on the significance of cytokines for the neuropathogenesis of HIV-associated dementia.

She is in the editorial boards of the Journal of NeuroVirology, the Journal of NeuroAIDS and of Neurobehavioral HIV Medicine, an open access journal. She is a member of the German Aids Society. She has written more than 150 papers, HIV/AIDS chapters in most of the German standard textbooks and three books. She has designed and conducted many national multicenter studies and participated in international studies.

Read More

Scope of the problem

Ignacio Pérez-Valero, M.D., Ph.D.

Reina Sofia University Hospital. Córdoba, Spain

Ignacio Pérez-Valero MD PhD is a 43 years-old Consultant Physician of Internal Medicine at the Reina Sofía University Hospital. Córdoba, Spain.

Read More

Screening or not screening, that is the question

Alejandro Arenas-Pinto, M.D.

University College of London, Centre for Clinical Research in Infection and Sexual Health. London, United Kingdom.

Alejandro Arenas-Pinto is a Venezuelan physician with training in infectious diseases and Tropical Medicine. Initially trained at Universidad Central de Venezuela, then completed his MSc in Infectious and Health in the Tropics at the London School of Hygiene and Tropical Medicine (Distinction) and obtained the Diploma in Tropical Medicine and Hygiene from the Royal College of Physicians. He gained his PhD from University College London (UCL) in 2006 on HIV and AIDS. Since 2004, Alejandro has been working at the UCL Centre for Clinical Research in Infection and Sexual Health, which is attached to one of the largest HIV clinics in the UK. Alejandro joined the Medical Research Council (MRC) Clinical Trials Unit at UCL as Senior Clinical Scientist in 2008 and has been working on national and international clinical trials on treatment of HIV disease ever since.

Read More


Paola Cinque, M.D.

Hospital San Rafael. Milan, Italy

She is currently working as senior physician at the Department of Infectious Diseases and responsible of the Neurovirology Research Unit at the Research Division of Immunology, Transplantation and Infectious Diseases of San Raffaele Scientific Institute, Milan, Italy, and as contract Professor of Infectious Diseases at San Raffaele University.

Her research group is mainly involved in studies on HIV Infection of the Central Nervous System, Progressive Multifocal Leukoencephalopathy and other HIV-associated CNS complications.

She is a panel member of the Italian HIV Treatment Guidelines, of the EACS Co-morbidities and of the Opportunistic Infections Guidelines, and of the NIH/CDC/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections.in HIV-Infected Adults and Adolescents.

Read More

Prevention of Neurocognitive impairment

Alan Winston, M.D.

St. Mary’s Hospital. London, United Kingdom

Alan Winston is a Professor of HIV and Genitourinary Medicine at Imperial College and Consultant Physician at St. Mary’s Hospital, London. He has an M.D. in antiretroviral clinical pharmacology and his research focuses on non-infectious co-morbidities associated with HIV-disease in the modern antiretroviral era, with a strong focus on central nervous system complications.

Dr. Alan Winston qualified from Glasgow University and undertook training in general medicine and HIV medicine in the UK and Australia. He leads the HIV and GU clinical trials unit at St. Mary’s hospital which runs over 20 studies at one time.

He is the principal clinical investigator on the POPPY study, a cohort study describing the incidence and nature of co-morbidities in HIV.

Read More

Treatment. Managing cognitive impairment in PLWH